140410 Stock Chart & Stats
₩59000.00
₩8,000.00(15.69%)
―
--
Day’s Range― - ―
52-Week Range₩35,850.00 - ₩179,900.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)117.08K
Market Cap
₩1.56T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.11
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,605,993
10 Day Avg. Volume148,271
30 Day Avg. Volume117,077
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
140410 FAQ
What was Mezzion Pharma Co., Ltd.’s price range in the past 12 months?
Mezzion Pharma Co., Ltd. lowest stock price was ₩35850.00 and its highest was ₩179900.00 in the past 12 months.
What is Mezzion Pharma Co., Ltd.’s market cap?
Mezzion Pharma Co., Ltd.’s market cap is ₩1.56T.
When is Mezzion Pharma Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Mezzion Pharma Co., Ltd.’s earnings last quarter?
Mezzion Pharma Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩174.664 earnings per share for the quarter, missing the consensus estimate of N/A by -₩174.664.
Is Mezzion Pharma Co., Ltd. overvalued?
According to Wall Street analysts Mezzion Pharma Co., Ltd.’s price is currently Undervalued.
Does Mezzion Pharma Co., Ltd. pay dividends?
Mezzion Pharma Co., Ltd. does not currently pay dividends.
What is Mezzion Pharma Co., Ltd.’s EPS estimate?
Mezzion Pharma Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mezzion Pharma Co., Ltd. have?
Mezzion Pharma Co., Ltd. has 30,605,993 shares outstanding.
What happened to Mezzion Pharma Co., Ltd.’s price movement after its last earnings report?
Mezzion Pharma Co., Ltd. reported an EPS of -₩174.664 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.635%.
Which hedge fund is a major shareholder of Mezzion Pharma Co., Ltd.?
Currently, no hedge funds are holding shares in KR:140410
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GC Biopharma Corp.
―
Hanmi Science Co., Ltd
―
Celltrion Pharm Inc.
―
Daewoong Pharmaceutical Co., Ltd.
―
Chong Kun Dang Pharmaceutical Corp.
―